Search Within

Jason Earl Chan

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (6)
Groups
  1. Department of Medicine (16)
  2. Epidemiology and Biostatistics (16)
  3. Hematologic Malignancies, Division of (16)
  4. Sarcoma Service (16)
  5. Solid Tumor Oncology Division (16)
  6. Weinberg Fellows (16)

More Groups

People
  1. Ciara Kelly (15)
  2. Evan Rosenbaum (15)
  3. Mark Dickson (15)
  4. Mary Keohan (15)
  5. Ping Chi (15)
  6. Sandra D'Angelo (15)

More People

Years
  1. 2024 (6)
  2. 2023 (4)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (1)
Publications
  1. Journal of Clinical Oncology (7)
  2. Annals of Oncology (3)
  3. Clinical Cancer Research (3)
  4. Nature Communications (2)
  5. Cancer Research Communications (1)
Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (4)
  3. Oxford University Press (3)
  4. Nature Publishing Group (2)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Thornton, K. A.; Movva, S.; Nacev, B. A.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
    Journal Article

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S. A.; Antonescu, C. R.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N. D.; Rana, S.; Zehir, A.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
    Journal Article

    D'Angelo, S. P.; Richards, A. L.; Conley, A. P.; Woo, H. J.; Dickson, M. A.; Gounder, M.; Kelly, C.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma
    Meeting Abstract

    Rosenbaum, E.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Thornton, K. A.; Chi, P.; Chan, J. E.; Nacev, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Chemotherapy and COVID-19 outcomes in patients with cancer
    Journal Article

    Jee, J.; Foote, M. B.; Lumish, M.; Stonestrom, A. J.; Wills, B.; Narendra, V.; Avutu, V.; Murciano-Goroff, Y. R.; Chan, J. E.; Derkach, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save